Public trial registry of the CCC-Munich

Trial 676- BCG Studie

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
676- BCG Studie
World
Full title
:

A Phase 3, randomized, comparator-controlled clinical Trial to study the efficiacy and safety of pembrolizumab in combination with BCG in participants with high-risk non-muscle invasive bladder cancer that is persistent or recurrent following BCG induction

World
Responsible organization
:
Urologie MRI Ismaninger Str.22 81675 München Germany Tum
Indications
Classification Code Description
- C67.9 Harnblase, nicht näher bezeichnet
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Urologie MRI Ismaninger Str.22 81675 München Germany Magnifier